A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence.“. London Journal of Medical and Health Research, [S. l.], v. 24, n. 6, p. 63–89, 2024. Disponível em: https://www.journalspress.uk/index.php/LJMHR/article/view/920. Acesso em: 22 aug. 2026.